retatrutide still hungry Diet: Why Eating Healthy Stalls Results Hungrier on Retatrutide? That's Okay

People with a history of certain medical conditions, such as medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, should not use GLP-1 medications

The evidence is promising, but its not a TikTok miracle

In vitro pharmacology characterised by Coskun and colleagues ( Cell Metab , 2022;34(9):1234-1247) reports that LY3437943 shows balanced glucagon and GLP-1 receptor activity with relatively greater GIP receptor activity, providing the ratio that underpins the compound's downstream metabolic profile in published trials

CrossRef Biological Activity of c-Peptide in Microvascular Complications of Type 1 DiabetesTime for Translational Studies or Back to the Basics

Additional benefits include improved cardiovascular outcomes in those with or at high risk of cardiovascular disease, and renoprotection

It also noted awareness of fraudulent compounded drugs and dosing errors that led to adverse patient events